• FREE

    Metastatic Melanoma: Novel Approaches in Immuno- and Molecularly–Targeted Therapy, Therapeutic Updates, and Best Practices in Involving the Patient in Care

    Metastatic Melanoma: Novel Approaches discusses the epidemiology, causes, clinical features, pathogenesis and immunotherapy in the treatment of metastatic melanoma.

    By the end of Metastatic Melanoma: Novel Approaches, you will be able to:
    • Describe the role of the immune system in cancer and cancer therapy in metastatic melanoma.
    • Distinguish between the different forms of therapy presently approved for metastatic melanoma and apply them to practice, taking into account the following: treatment modalities and the recent clinical trial evidence supporting them.
    • Describe emerging (investigational) therapies for metastatic melanoma
    • Describe the challenges and barriers to care associated with treating patients with metastatic melanoma

    Target Audience:
    Oncologists, dermatologists, and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in oncology; and any other healthcare professionals with an interest in or who clinically encounter patients with malignant melanoma.

    • Cost: Free
    • Credit hours: 1.25
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: December 4, 2017
    • Expiration of CME credit: December 4, 2019
  • FREE

    Metastatic Melanoma: Updates from ASCO 2017

    Melanoma is a tumor of the melanocytes whose tissue of origin is primarily the skin, although it may also develop occasionally in the: gastrointestinal, genitourinary, or respiratory tracts; ocular or mucosal tissue; or meninges.

    Metastatic Melanoma: Updates from ASCO 2017 summarizes major findings from ASCO 2017 related to Metastatic Melanoma, including clinical trial data relevant to both community and health-system practice and recognized barriers to implementing those findings in practice

    After reviewing Metastatic Melanoma: Updates from ASCO 2017 you will be able to:
    • Summarize the most impactful findings presented at ASCO 2017 relating to Metastatic Melanoma and apply them to patient cases, taking into account any relevant barriers to care.

    Target Audience:
    Oncologists, dermatologists, and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in oncology; and any other healthcare professionals with an interest in or who clinically encounter patients with malignant melanoma.

    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: September 19 2017
    • Expiration of CME credit: September 19 2019
  • FREE

    ScientiaCME Dermatology CME

    ScientiaCME Dermatology CME has three selections:
    Psoriatic Arthritis: Therapeutic Updates and Optimizing Treatment (1 hr CME)
    Basal Cell Carcinoma (BCC): Therapeutic Updates, Best Practices, and the Role of Personalized Patient Care (1 hour CME)
    Psoriasis: Best Practices, Barriers to Care, and Emerging Therapies in Medication Management (1 hr CME)

    In order to get credit from ScientiaCME, you must first establish a username and password.

    Target Audience: Physicians focusing on Allergy, Dermatology

    • Cost: Free
    • Credit hours: 3
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Expiration of CME credit: Two years after release
  • FREE

    Systemic Sclerosis Interstitial Lung Disease (SSc-ILD): Optimizing Treatment Strategies

    Systemic Sclerosis Interstitial Lung Disease (SSc-ILD): Optimizing Treatment Strategies is a free CME course that looks into the diangosis and treatment of Systemic Sclerosis Interstitial Lung Disease (SSc-ILD).

    Topics covered in this course include

    • SSc-ILD Epidemiology and risk factors
    • SSc-ILD Pathophysiology
    • SSc-ILD Diagnosis
    • Treatment of SSc-ILD
    • SSc-ILD

    After completing this course, you will better be able to:

    • Describe the etiology of SSc-ILD and its impact on patient clinical presentation and available pharmacotherapeutic treatments
    • Describe the prevalence, clinical features, and presentation of SSc-ILD
    • Evaluate treatments plans for SSc-ILD patients and suggest appropriate therapies, where applicable, based on individual presentations
    • Describe present and emerging drug therapies for management of SSc-ILD and apply them to patient cases taking into account the patient’s history
    • Describe clinical and logistical challenges associated with treating and educating patients with SSc-ILD

    Target audience: The following HCPs: pulmonologists, rheumatologists, primary care physicians, pathologists, dermatologists; physician assistants, nurse practitioners, nurses, and pharmacists specializing in pulmonology; and any other HCPs who have an interest in or otherwise clinically encounter patients with Ssc-ILD.

    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: August 20, 2018
    • Expiration of CME credit: July 20, 2020